XOMA Royalty (XOMA) Other Accumulated Expenses (2011 - 2026)

XOMA Royalty's (XOMA) quarterly Other Accumulated Expenses came in at $747000.0 in Q1 2026, up 474.62% year-on-year from $130000.0 in Q1 2025, and up 598.13% quarter-over-quarter from $107000.0 in Q4 2025.

XOMA Royalty (XOMA) Other Accumulated Expenses (2011 - 2026) Analysis & Trends

XOMA Royalty has disclosed Other Accumulated Expenses across 16 years of filings, most recently posting $747000.0 for Q1 2026.

  • Other Accumulated Expenses for Q1 2026 came in at $747000.0, up 474.62% year-over-year; the trailing twelve-month figure through Mar 2026 was $747000.0 (up 474.62% YoY), and the FY2025 annual result was $107000.0, down 29.14% from the prior year.
  • Other Accumulated Expenses came in at $747000.0 for Q1 2026 at XOMA Royalty, up from $107000.0 in the prior quarter.
  • In the past five years, Other Accumulated Expenses ranged from a high of $747000.0 in Q1 2026 to a low of $20000.0 in Q2 2022.
  • The 5-year median for Other Accumulated Expenses is $100000.0 (2023), against an average of $210294.1.
  • Across the five-year window, Other Accumulated Expenses jumped 2315.0% in 2024 and dropped 29.14% in 2025, its largest moves.
  • XOMA Royalty's Other Accumulated Expenses stood at $40000.0 in 2022, then jumped by 125.0% to $90000.0 in 2023, then soared by 67.78% to $151000.0 in 2024, then dropped by 29.14% to $107000.0 in 2025, then soared by 598.13% to $747000.0 in 2026.
  • The last three Other Accumulated Expenses figures came in at $747000.0 (Q1 2026), $107000.0 (Q4 2025), and $456000.0 (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Alterity Therapeutics 762,369.55 Bn 762,369.51 Bn -
2 Belite Bio 55,096.00 Bn 55,096.00 Bn -
3 Quantum Biopharma 17,755.80 Bn 17,755.79 Bn -
4 Legend Biotech 3,486.00 Bn 3,485.71 Bn 242.10 Mn
5 Akari Therapeutics 1,737.42 Bn 1,737.41 Bn -
6 Evaxion A 1,551.28 Bn 1,551.26 Bn -
7 Psyence Biomedical 227.32 Bn 227.31 Bn -
8 Vertex Pharmaceuticals 110.84 Bn 103.59 Bn 2.59 Bn
9 Abivax 91.71 Bn 91.71 Bn -
10 XOMA Royalty 5.48 Mn -60.60 Mn -

Historic Data

Download Data
DateValue
Mar 31, 2026 747,000.00
Dec 31, 2025 107,000.00
Sep 30, 2025 456,000.00
Jun 30, 2025 576,000.00
Mar 31, 2025 130,000.00
Dec 31, 2024 151,000.00
Sep 30, 2024 445,000.00
Jun 30, 2024 483,000.00
Mar 31, 2024 100,000.00
Dec 31, 2023 90,000.00
Sep 30, 2023 30,000.00
Jun 30, 2023 20,000.00
Mar 31, 2023 100,000.00
Dec 31, 2022 40,000.00
Sep 30, 2022 30,000.00
Jun 30, 2022 20,000.00
Mar 31, 2022 50,000.00
Dec 31, 2021 40,000.00
Mar 31, 2021 50,000.00
Dec 31, 2020 84,000.00